对抗体治疗药物的成本和供应考虑
Chun Chen1, Zoe Garcia1, David Chen1
1Chemistry, Manufacturing and Controls, Bill & Melinda Gates Medical Research Institute, Cambridge, MA, USA.
mAbs
|January 20, 2025
概括
单克隆抗体 (mAbs) 是成功的治疗方法,但由于高成本和供应问题,它们面临采用障碍. 本研究探讨了mAb定价,制造和经济建模,以提高可负担性和确保患者获得.
科学领域:
- 生物制药制造业 生物制药制造业
- 治疗性蛋白质 治疗性蛋白质
- 药物开发经济学 药物开发经济学
背景情况:
- 单克隆抗体 (mAbs) 和它们的衍生物已经证明了显著的治疗成功.
- 这些生物制剂的广泛采用受到高成本和供应链复杂性的限制.
研究的目的:
- 分析mAbs和mAb衍生疗法的成本结构和定价.
- 确定提高可负担性和确保稳定的供应的战略.
- 探索影响成本和可用性的生物制造创新.
主要方法:
- 审查当前的mAb定价和成本结构.
- 讨论主流和新兴的生物制造技术.
- 在行业中使用的过程经济学建模工具的总结.
主要成果:
- 高价格和供应挑战是mAb治疗的主要限制因素.
- 生物制造创新为降低成本和改善供应提供了潜力.
- 过程经济学评估在整个产品开发过程中至关重要.
结论:
- 了解成本和供应动态对于行业的竞争力至关重要.
- 战略方法可以减轻供应挑战,并扩大患者获得mAb疗法的机会.
- 经济建模有助于驾竞争环境,并确保治疗的可用性.
更多相关视频
07:53Activated Cross-linked Agarose for the Rapid Development of Affinity Chromatography Resins - Antibody Capture as a Case Study
Published on: August 16, 2019
9.2K
04:24Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
Published on: June 16, 2023
1.4K
相关概念视频
Antibody Structure
58.9K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
58.9K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
Antibody Structure and Classes
758
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
758
Immunoprecipitation
5.3K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
5.3K
